GlassScriptPhysician profile
Mohan C Deochand
NPI 1518976729
$11,605.09
in general payments reported to CMS, 2019-2025
59 companies · $1,735 in 2025
The $1,735 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $990 · 2020: $1,585 · 2021: $2,107 · 2022: $2,248 · 2023: $1,232 · 2024: $1,708 · 2025: $1,735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,675.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $901.66 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $738.71 | 2019-2024 | |
| Biogen, INC. | $612.14 | 2019-2025 | Vumerity, Leqembi, Tysabri |
| Supernus Pharmaceuticals, INC. | $591.00 | 2019-2021 | |
| Harmony Biosciences LLC | $576.80 | 2020-2025 | Wakix |
| Mallinckrodt Hospital Products INC. | $551.89 | 2020-2025 | Acthar |
| Abbvie INC. | $535.49 | 2021-2025 | Ubrelvy, Qulipta |
| Adamas Pharmaceuticals, INC. | $531.91 | 2019-2021 | |
| Neurelis, INC. | $506.85 | 2020-2025 | Valtoco |
| Pfizer INC. | $470.97 | 2019-2025 | |
| Lilly USA, LLC | $403.50 | 2019-2025 | Zepbound, Kisunla, Emgality |
| Amgen INC. | $334.70 | 2019-2024 | Aimovig, Uplizna |
| Eisai INC. | $331.05 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $324.74 | 2019-2024 | Ultomiris |
| Lundbeck LLC | $320.76 | 2019-2025 | Vyepti |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohan Deochand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.